Skip to main content

United States News All stories

Every story in this section, newest first — page 298 of 373.

Grafa

Bullish reports record operational growth amid massive accounting loss

Bullish (NYSE:BLSH) shares were volatile on Thursday after the digital asset platform reported a complex fourth quarter: while core operational metrics hit record highs, the bottom line was hit by a substantial non-cash net loss related to the fair value accounting of its massive digital asset holdings.

Read more: Bullish reports record operational growth amid massive accounting loss
Grafa
Health

Cardinal Health surges as specialty pharma and GLP-1 demand drive guidance raise

Cardinal Health (NYSE:CAH) delivered a blowout second quarter on Thursday, significantly raising its full-year outlook as the drug wholesaler cashes in on robust demand for specialty therapeutics and high-margin GLP-1 medications.

Read more: Cardinal Health surges as specialty pharma and GLP-1 demand drive guidance raise
Grafa
Health

Prestige Consumer Healthcare narrows outlook amid eye care supply strain

Prestige Consumer Healthcare (NYSE:PBH) reported fiscal third-quarter results on Thursday that featured a revenue beat but an earnings miss, as the company worked to stabilize its supply chain for key brands like Clear Eyes® amid a "challenging consumer backdrop."

Read more: Prestige Consumer Healthcare narrows outlook amid eye care supply strain
Grafa
Health

Alvotech nears regulatory filing as Entyvio biosimilar meets study goals

Alvotech (NASDAQ:ALVO) announced positive top-line results from a pivotal clinical study for its biosimilar candidate to Entyvio, positioning the Icelandic biotech to challenge one of the top-selling gastrointestinal treatments in a $6.4 billion market.

Read more: Alvotech nears regulatory filing as Entyvio biosimilar meets study goals